Show simple item record

dc.contributor.authorElimian, Kelly Osezele
dc.contributor.authorAderinola, Olaolu
dc.contributor.authorIgumbor, Ehimario
dc.date.accessioned2021-09-23T10:40:01Z
dc.date.available2021-09-23T10:40:01Z
dc.date.issued2021
dc.identifier.citationElimian, K. O. et al. (2021). Assessing the capacity of symptom scores to predict COVID-19 positivity in Nigeria: A national derivation and validation cohort study. BMJ Open, 11(9), e049699. https://doi.org/10.1136/bmjopen-2021-049699en_US
dc.identifier.issn2044-6055
dc.identifier.uri10.1136/ bmjopen-2021-049699
dc.identifier.urihttp://hdl.handle.net/10566/6795
dc.description.abstracts This study aimed to develop and validate a symptom prediction tool for COVID-19 test positivity in Nigeria.A cohort of 43 221 individuals within the national COVID-19 surveillance dataset from 27 February to 27 August 2020. Complete dataset was randomly split into two equal halves: derivation and validation datasets. Using the derivation dataset (n=21 477), backward multivariable logistic regression approach was used to identify symptoms positively associated with COVID-19 positivity (by real-time PCR) in children (≤17 years), adults (18–64 years) and elderly (≥65 years) patients separately.en_US
dc.language.isoenen_US
dc.publisherBMJ Publishing Groupen_US
dc.subjectCOVID-19en_US
dc.subjectNigeriaen_US
dc.subjectSymptom predictionen_US
dc.subjectPublic healthen_US
dc.subjectCOVID-19 infectionen_US
dc.titleAssessing the capacity of symptom scores to predict COVID-19 positivity in Nigeria: A national derivation and validation cohort studyen_US
dc.typeArticleen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record